Skip to main content
. 2019 Feb 28;14(3):421–430. doi: 10.2215/CJN.10590918

Figure 2.

Figure 2.

Trends in low-income subsidy payments from 2008–2013. Average annualized payments (2013 US dollars) by the Medicare Part D low-income subsidy program for overall, brand-name, and generic (A) tacrolimus and (B) mycophenolic acid by organ type. Patients not receiving the low-income subsidy were excluded from this analysis.